Filter
907
Filtered Results: 907
Text search:
medicine
manufacturing
Featured
Recommendations
79
New Publications
220
Language
Document type
No document type
413
Studies & Reports
199
Guidelines
143
Strategic & Response Plan
53
Manuals
49
Fact sheets
23
Situation Updates
11
Training Material
7
Resource Platforms
4
Brochures
2
Infographics
1
Online Courses
1
Videos
1
Countries / Regions
India
42
Kenya
35
Global
33
Nigeria
24
Uganda
23
Ethiopia
23
Ghana
20
Western and Central Europe
16
Tanzania
15
South Africa
15
Africa
14
Nepal
13
Zambia
13
Sierra Leone
12
Rwanda
12
Bangladesh
12
Lesotho
10
Philippines
10
South–East Asia Region
9
Malawi
8
West and Central Africa
8
East and Southern Africa
8
Liberia
8
Myanmar / Burma
8
Ukraine
7
Syria
7
Zimbabwe
7
Latin America and the Carribbean
7
Namibia
7
Botswana
7
Eastern Europe
5
Indonesia
5
Thailand
4
USA
4
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eswatini/ Swaziland
4
Cameroon
3
Albania
3
Asia
3
Moldova
3
Sri Lanka
3
Russia
3
South Sudan
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Laos
2
Senegal
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Mauritius
2
United Kingdom
2
Sudan
2
Yemen
2
Serbia
1
Australia
1
Afghanistan
1
Mongolia
1
Jordan
1
Germany
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Brazil
1
Egypt
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
344
Clinical Guidelines
71
Public Health
42
Pharmacy & Technologies
34
Key Resources
29
Women & Child Health
16
Capacity Building
7
Toolboxes
COVID-19
106
Pharmacy
93
AMR
91
HIV
59
Planetary Health
46
TB
35
Mental Health
30
Rapid Response
23
NTDs
17
Global Health Education
17
NCDs
16
Ebola
14
Disability
13
Conflict
13
Specific Hazards
10
Caregiver
9
Natural Hazards
7
Health Financing Toolbox
7
Refugee
4
Cholera
3
Zika
1
Polio
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...
Antibiotics use with care
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its objectives are to minimize...
Textes du Codex concernant la résistance aux antimicrobiens d’origine alimentaire
Textos del Codex sobre la resistencia a los antimicrobianos transmitida por los alimentos
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become r...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ...
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased morbidity and mortality in infectious diseases. Sri La...
Antimicrobial resistance has become a serious public health threat for effective treatment of an ever increasing range of infections caused by bacteria, parasites, viruses and fungi. When infections can no longer be treated by first-line antibiotics, other antibiotics must be used, which are both mo...
Supporting the food and agriculture sectors in implementing the Global Action Plan on Antimicrobial Resistance to minimize the impact of antimicrobial resistance
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
Start Free Stay Free AIDS Free - 2020 report
recommended
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
